Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Sep;91(9):1122-4.
doi: 10.1136/bjo.2007.115386. Epub 2007 Mar 23.

Effects of intravitreal triamcinolone acetonide injection with and without preservative

Affiliations

Effects of intravitreal triamcinolone acetonide injection with and without preservative

Mauricio Maia et al. Br J Ophthalmol. 2007 Sep.

Abstract

Aims: To evaluate the effects of intravitreal injection of preservative-free triamcinolone acetonide (PFTA) and TA containing preservative (KE).

Methods: A retrospective review was conducted of 646 intravitreal 4 mg/0.1 ml steroid injections in 471 eyes. A total of 577 intravitreal injections of PFTA and 69 injections of KE were administered in non-randomised eyes. No supernatant removal from KE was performed. Non-infectious endophthalmitis was defined as pseudohypopyon/hypopyon with or without an inflammatory reaction that regressed after steroid eye drop instillation. Ocular hypertension was defined as more than 23 mm Hg with Goldman applanation tonometry. Patients were followed and examined 1, 7 and 28 days, and 3, 4, 6 and 12 months after injection and annually thereafter. Statistical analysis was performed using Fisher's exact test and Chi(2) test. p Values <0.05 were considered significant.

Results: Both groups did not differ in demographics (p>0.05). Follow-up ranged from 6 to 57 months (mean 13, SD 7.5). Ocular hypertension was present in 127 eyes (20%), but both groups did not differ significantly (p = 0.167). Four eyes (3.15%) required trabeculectomy. Non-infectious endophthalmitis developed in 12 eyes (1.9%) and varied significantly in both groups (p = 0.005). One eye developed bacterial endophthalmitis (0.15%).

Conclusions: Non-infectious endophthalmitis was observed significantly more often after KE injections (7.3%) than after PFTA injections (1.2%) (p<0.05). An inflammatory reaction was more clinically relevant in the KE group than in the PFTA group.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors have no proprietary interest in any aspect of this report.

Comment in

References

    1. Jonas J B, Kreissig I, Degenring R. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases. Prog Retin Eye Res 200524587–611. - PubMed
    1. Horio N, Horiguchi M, Yamamoto N. Triamcinolone‐assisted internal limiting membrane peeling during macular hole surgery. Arch Ophthalmol 200512396–99. - PubMed
    1. Jonas J B, Kreissig I, Degenring R F. Endophthalmitis after intravitreal injection of triamcinolone acetonide. Arch Ophthalmol 20031211663–1669. - PubMed
    1. Gilles M C, Simpson J M, Billson F A.et al Safety of intravitreal injection of triamcinolone: results from a clinical trial. Arch Ophthalmol 2004122336–342. - PubMed
    1. Jonas J B, Kreissig I, Degenring R F. Retinal complications of intravitreal injections of triamcinolone acetonide. Graefes Arch Clin Exp Ophthalmol 2004242184–188. - PubMed

Publication types

MeSH terms